INTRODUCTION
Prostate cancer (PCa) is the most common cancer in the worldwide and its morbidity,mortality is the first and second common cancer in men, respectively [1] . RP is the standard therapy for patients with localized PCa [2] . However, open retropubic radical prostatectomy (RRP) is associated with higher overall complications, including estimated blood loss (EBL), wound infections. With the development of surgical techniques, laparoscopic techniques and robot assisted surgeries have become a very popular procedure for the management of urological disease throughout the world [3] . Compared with RRP, the advantages of laparoscopic radical prostatectomy (LRP) are less EBL, fewer complications, better cosmetic effect and shorter hospital stay [4] . The disadvantages of LRP is lack of 3D visualization and poor ergonomics.
As alternatives to open surgery, RARP has became a predominant procedure for the treatment the localized prostate cancer in the world [5] . Assessing of the robotic Clinical Research Paper www.impactjournals.com/oncotarget surgery by expert indicate better ergonomics and quicker learning curve, but its shortage is high cost of the robotic surgery system.
In recent years, many experts have reported on comparative study of RARP and open RRP. And some meta-analysis were performed to evaluate the advantages and disadvantages of two approaches, including perioperative outcomes, oncologic outcomes [5] . Their early experience showed that the outcomes of this approach with fewer overall complications, quicker convalescence, and lower EBL and transfusion [5] [6] [7] . However, the outcomes of RARP compared with RRP have not been fully evaluated, and no conclusive results are available. Therefore, a systematic review and metaanalysis of the included published studies was performed to compare RARP with RRP.
RESULTS

Characteristics of eligible studies
According to search strategy, the included 78 studies [4, assessing RARP vs. RRP met the inclusion criteria and were applied to perform this meta-analysis ( Figure 1 ). Those studies include forty-three retrospective and thirty-five prospective studies and were listed in Table  1 .
Quality of the studies and level of evidence (Table 1) In this meat-analysis, the Newcastle-Ottawa Scale quality assessment method of the observational studies [86] , and the US Preventive Services Task Force grading system [87] were applied to evaluate the quality of included studies. Twenty studies scored seven stars and were evaluated as the high quality studies. Additionally, The clinical variables of RARP and RRP were extracted independently from included literatures ( Table 1) .
Description of included studies and patients Demographics (Table 2)
Patients underwent RARP are younger (WMD = -1.00 years; 95% CI: -1.56 to -0.44; P < 0.001) ( Figure  S1 Table 2 ). (Figure 2 ). Pooling data of 13 studies [10, 21, 23, 29, 30, 34, 40, 60, 70, 75, 78, 84, 85] results showed that RARP has less intraoperative blood loss (WMD = -507.67ml; 95% CI: -633.21 to -382.12; P < 0.001) ( Figure 3 ).
Outcomes of perioperative variables (
Transfusion rate and postoperative recovery
Pooled data from the 26 studies [9, 10, 14, 21, 23, 24, 26, 29, 30, 34, 35, 40, 44-46, 54, 59, 64, 72, 73, 78, 80, 82, 84] reported transfusion rate between RARP and RRP, and the results showed that RARP was associated with lower transfusion rate (OR = 0.13; 95% CI: 0.08 to 0.21;P < 0.001) than RRP ( Figure 4 ). Pooling data of 5 studies reported on the time to remove catheter, the forest plot showed that RARP had shorter time to remove catheter than RRP group (WMD = -3.04; 95% CI: -4.59 to -1.49; P < 0.001) ( Figure S5 ). And pooling date of 11 studies [10, 23, 24, 34, 53, 54, 64, 75, 78] reported on length of hospital stay (LOS), the forest plot showed that RARP had a shorter LOS than RRP (WMD = -1.62; 95% CI: -2.42 to -0.82; P < 0.001) ( Figure 5 ). RARP=robot-assisted radical prostatectomy; RRP=retropubic radical prostatectomy; OR = odds ratio; WMD = weighted mean difference; CI = confidence interval; BMI = body mass index. = 7 (OR: 1.17; 95% CI: 1.04 to 1.33; P = 0.01; Figure  6 ) performed RARP and more Gleason score ≥8 (OR: 0.68; 95% CI: 0.60 to 0.78; P < 0.001; Figure 6 ) in RRP. However, there were no statistical differences with respect to Gleason score≤6 (OR: 1.04; 95% CI: 0.91 to 1.18; P = 0.61; Figure 6 ) and pathologic T stage in the two groups ( Figure S6 ,7,8) (Table 5) .
Positive surgical margins and lymph node yield( RARP=robot-assisted radical prostatectomy; RRP= retropubic radical prostatectomy; OR = odds ratio; WMD = weighted mean difference; CI = confidence interval; UTI=urinary tract infection; DVT=deep venous thrombosis. RARP=robot-assisted radical prostatectomy; RRP=retropubic radical prostatectomy; OR = odds ratio; WMD = weighted mean difference; CI = confidence interval; PSM=positive surgical margins; † value of WMD. 0.04) (Figure 7 ). PSM rates in pT3 cancers was higher in RARP group (OR:1.46; 95% CI: 1.27 to 1.67; P < 0.001) (Figure 8 ). However, the results showed that PSM rates in pT2 cancers was lower in RARP (OR:0.77; 95% CI: 0.63 to 0.95; P = 0.01) (Figure 9 ). Four studies [20, 43, 60, 73] comparing mean lymph node yield and the results showed that lymph node yield is higher in RARP (WMD: 1.61; 95% CI: 1.18 to 2.05; P < 0.001)( Figure S9 ), and 16 studies [20, 26, 33, 34, 39, 49, 58, 61, 64-68, 73, 84, 85] reported on positive lymph node, There was a statistical differences decreased positive lymph node in RARP than RRP (OR:0.45; 95% CI: 0.31 to 0.65; P < 0.001)( Figure  10 ).
Outcomes of complications(Table 4)
Pooling data from 25 studies [9, 11, 17, 23, 24, 26, 27, 29, 31, 34, 35, 40, 42, 46, 48, 52-54, 59, 64, 72, 73, 80, 82, 84] reported on overall complications, RARP had lower overall complications in the RARP than RRP(OR:0.43; 95% CI: 0.32 to 0.58; P < 0.001) ( Figure 11 ). Next, a meticulous classification of overall complications showed that RRP had a higher incidence of rectal injury(OR:0.16; 95% CI: 0.07 to 0.39; P < 0.001) ( Figure S10 RARP=robot-assisted radical prostatectomy; RRP=retropubic radical prostatectomy; OR = odds ratio; WMD = weighted mean difference; CI = confidence interval. www.impactjournals.com/oncotarget
Urinary continence recovery and potent recovery (Table  4) Pooling data of 9 studies [9, 21, 26, 50, 62, 70, 81, 83, 84] reported on 3-mo and 12-mo urinary continence recovery between two groups. The forest plot showed that there were no statistical differences on the 3-mo and 12-mo urinary continence between two groups (3mo: OR:1.54; 95% CI: 0.92 to 2.58; P = 0.10; 12mo: OR:1.03; 95% CI: 0.84 to 1.27; P = 0. Figure S21 ). And the 3-and 12-mo potent recovery rate of RARP were better than RRP group, respectively (OR:3.19; 95% CI: 1.19 to 8.56; P = 0.02; OR: 2.37; 95% CI: 1.30 to 4.33; P = 0.005,respectively)( Figure 13,14) .
Biochemical recurrence free survival and Readmission rate(Table 5)
Pooling data from 10 studies [12, 16, 34, 49, 56, 61, [65] [66] [67] 74] reported on biochemical recurrence(BCR) free survival, these results showed that RARP had a better BCR free survival than RRP(OR:1.33; 95% CI: 1.01 to 1.76; P = 0.04) (Figure 15 ). Pooling data from 7 studies [22, 35, 38, 53, 54, 59, 75] reported on readmission rate, the forest plot showed that RARP had a lower readmission rate than RRP(OR:0.83; 95% CI: 0.74 to 0.94; P = 0.002) ( Figure  16 ).
Sensitivity analysis
42 qualified studies with patients' baseline characteristic consistency(age, pre-PSA, BMI, prostate volume, P > 0.5) are analyzed by sensitivity analysis ( Table 6 ). Compared with the original analysis, there was no change in the significance of any other outcomes except that readmission rate(P = 0.002 vs P = 0.13), and BCR for free survival(P = 0.04 vs. P = 0.55) were significantly different in sensitivity analysis. The method of sensitivity analysis can reduce the heterogeneity of studies to a certain extent.
DISCUSSION
The incidence of prostate cancer and its mortality is the first and the second common cancer in man, respectively [1] . Our results indicated that RARP seemed to have an younger age (WMD: -1.00; P < 0.001), and to have the lower level of pre-PSA (WMD: -0.93; P < 0.001) than RRP group, and that these differences are primarily due to surgeon's preference for surgical modality. Another reason is that the younger is more easier to choose new approach. However, there is no difference on BMI and prostate volume between the two groups. Sensitivity analysis showed that there was no change in the significance of any other outcomes except that readmission rate(P = 0.002 vs P = 0.13) and BCR for free survival(P = 0.04 vs. P = 0.55).It demonstrated that selection bias of demographic and clinical data of patients is small between two groups.
Novara G et al [6] evaluated oncologic outcomes of RARP and RRP, and the results indicated that RARP had less EBL and transfusion rate than RRP. Their results presented similar results and strengthened our results. The other analyzed parameters operative time and complication rate were similar. However, in our meta-analysis, RARP had longer operative time than RRP(WMD:39.85min, P<0.001), which likely reflects the early learning curve with RARP. But the learning curve indicated that operative time was decreased with growing operative experience and it won't influenced operative outcomes [88] .
With regard to the pathologic outcomes, patients underwent RARP had more pathological Gleason score = 7, less pathological Gleason score ≥8, higher lymph node yield and fewer positive lymph node than RRP. However, the pathological T stage is no significant difference between the RARP and RRP group. LN yield was deemed an indicator of surgical quality by many surgeons [89] . RARP had a higher LN yield than RRP, the reason is that RARP has meticulous dissection with 3D vision and decrease the intraoperative blood loss which made the surgeon have more time and patience to acquiring higher LN yield. Therefore, the oncological outcomes in terms of PSM for T3 is higher in RARP than RRP. With the results that BCR free survival was higher in RARP than RRP. Some studies showed that the predictors of BCR were preoperative PSA. Gleason score, pathological stage, and PSM [49] .
The experts suggested that patient outcomes and surgical approach were mainly required to improve for an accurate characterization of complications [90] . In our meta-analysis, Patients underwent RARP had fewer overall complications than RRP. The possible reason may be associated with lower EBL and less transfusion rate in RARP. Then a comprehensive classification of complications indicated that RRP had a higher incidence of rectal injury, pulmonary embolism, wound infections, bladder neck contracture, urinary retention, deep venous thrombosis, urinary leakage, lymphocele, and obturator nerve injury. There were no significant differences with regard to ileus and UTI between two groups.
Ficarra V et al [91] compared RARP with RRP with respect to 12-mo urinary continence. Their results indicated that RARP had a better 12-mo urinary continence recovery than RRP(OR:1.53; P = 0.03). However, our results indicated that there were no statistical differences with regard to 3-mo and 12-mo urinary continence in two groups. The urinary continence receiving RP is influenced by preoperative patient characteristics, surgical techniques, and so on. Some studies found that patient age [92, 93] , BMI [94] , comorbidity index [95] , and prostate volume [96, 97] were also the potential predictors of urinary incontinence. Increasing age, higher BMI, and large prostate volume are correlated with high risk of urinary incontinence who underwent RP. However, the 3-and 12-mo potent recovery rate of RARP was also better than RRP group, respectively. Analysis of predictors indicated that peroperative parameters might influence potency results. Relevant predictors included age at surgery, baseline erectile function, and comorbidities [98] . Other authors also confirmed that age and baseline erectile function of patients were affected the potent recovery in nerve-sparing RARP [93, 99] .
On the other hand, we found better BCR free survival and lower readmission rate in RARP group in the original analysis. The reason is that meticulous dissection, lower blood loss and complications might provide patients better oncologic prognosis in RARP group. However, we observed no statistical differences between RARP and RRP in sensitivity analysis. Therefore, multicenter, large sample, long follow-up RCTs are required to prove our findings.
Nevertheless, there were several limitations when analyzing and interpreting results in our meta-analysis. The major limitation is lack of well designed prospective, randomized control studies in our meta-analysis. Secondly, there existed heterogeneities of studies, especially in the comparing of the continuous data such as the length of hospital stay, operative time. whereas these parameters were influenced by the heterogeneities of patients' conditions, surgeon's surgical skills and the sample size of studies. In addition, short follow-up duration may have an influence on the confidence of outcomes. In the future, well-designed, prospective, multicenter randomized control studies are required to help us better demonstrate the advantages as well as drawbacks of this novel approach.
MATERIALS AND METHODS
Literature search strategy
To update previous systematic review [5-7, 91, 98, 100, 101] , a systematic review of published literature was performed according to the Cochrane Handbook recommendations [102] . No ethic issues get involved in this article. A systematic dissertion was conducted using Medline, Embase, Pubmed, CNKI, and all relevant studies had been identified by the Cochrane Library. The following key words were used: "comparative studies", "retropubic", "open", "radical prostatectomy ", "Da Vinci", "robot-assisted", and "prostate cancer".
Data extraction and outcomes of interest
Two of the authors(JKH and TK) extracted data from the selected studies including: author identification, country, publication year, study design, age, No. of patients, operative approaches were mentioned previously, and results of intervention. All disagreements about eligibility were reached a consensus through authors discussion. Perioperative outcomes including operative time, EBL, LOS, overall complications, and oncological outcomes were compared between the two methods from all the studies that were finally selected. Overall complications were graded on the basis of the ClavienDindo system [103] .
Inclusion criteria and exclusion criteria
Studies should satisfy the following requirements: (1) to compare RARP with RRP, (2) to display on outcome of two approaches, (3) to document the surgery as RARP or RRP, (4) to clearly document indications for prostatectomy with prostate cancer. Studies will be excluded if (1) the study was not satisfied inclusion criteria or (2) the outcomes of literature were not mentioned or the parameters were impossible to analysis for either RARP or RRP from the published findings and (3) studies focusing on pure robot surgery system and/or on singlesite techniques.
Study quality assessment and level of evidence
In accordance with the criteria of Centre for Evidence-Based Medicine in Oxford, we evaluated the level of evidence(LOE) of included sixteen studies. The Jaded Score was applied to evaluated the methodological quality of RCTs [104] . The Newcastle-Ottawa Scale(NOS) was applied to assessed the methodological quality of nonRCTs observational studies [86, 105] . Two authors(JKH and TK) evaluated the quality of the studies and discrepancies were rechecked by the third reviewer(CZQ) and consensus was achieved by discussion.
Statistical analysis
All meta-analysis were conducted by Review Manger 5.3(Cochrane Collaboration, Oxford, UK). Continuous and dichotomous variables were calculated by weighted mean differences (WMDs) and odds ratios(ORs). All analysis results were reported with 95% confidence intervals(CIs). I 2 test and chi-square-based Q test were applied to evaluated the quantity of heterogeneity, and when I 2 > 50%, the evidence was considered to have substantial heterogeneity, the random-effects(RE) model would be applied, otherwise, the fixed effects(FE) model was applied. The presence of publication bias was evaluated by Egger's test and funnel plot. Sensitivity analysis was used to estimate the influence of studies with a high risk of bias on the overall effect.
